301 related articles for article (PubMed ID: 21517798)
1. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.
Trøstrup H; Lundquist R; Christensen LH; Jorgensen LN; Karlsmark T; Haab BB; Agren MS
Br J Dermatol; 2011 Aug; 165(2):292-301. PubMed ID: 21517798
[TBL] [Abstract][Full Text] [Related]
2. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
Nwomeh BC; Liang HX; Cohen IK; Yager DR
J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
[TBL] [Abstract][Full Text] [Related]
3. Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds.
Eming SA; Koch M; Krieger A; Brachvogel B; Kreft S; Bruckner-Tuderman L; Krieg T; Shannon JD; Fox JW
J Proteome Res; 2010 Sep; 9(9):4758-66. PubMed ID: 20666496
[TBL] [Abstract][Full Text] [Related]
4. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
5. The relationship between cytokine concentrations and wound healing in chronic venous ulceration.
Gohel MS; Windhaber RA; Tarlton JF; Whyman MR; Poskitt KR
J Vasc Surg; 2008 Nov; 48(5):1272-7. PubMed ID: 18771884
[TBL] [Abstract][Full Text] [Related]
6. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation.
Herrick S; Ashcroft G; Ireland G; Horan M; McCollum C; Ferguson M
Lab Invest; 1997 Sep; 77(3):281-8. PubMed ID: 9314951
[TBL] [Abstract][Full Text] [Related]
8. Can Wound Exudate from Venous Leg Ulcers Measure Wound Pain Status?: A Pilot Study.
Goto T; Tamai N; Nakagami G; Kitamura A; Naito A; Hirokawa M; Shimokawa C; Takahashi K; Umemoto J; Sanada H
PLoS One; 2016; 11(12):e0167478. PubMed ID: 27936243
[TBL] [Abstract][Full Text] [Related]
9. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer.
Rayment EA; Upton Z; Shooter GK
Br J Dermatol; 2008 May; 158(5):951-61. PubMed ID: 18284390
[TBL] [Abstract][Full Text] [Related]
10. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers--correlations to healing status.
Wallace HJ; Stacey MC
J Invest Dermatol; 1998 Mar; 110(3):292-6. PubMed ID: 9506452
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alfa in nonhealing venous leg ulcers.
Charles CA; Romanelli P; Martinez ZB; Ma F; Roberts B; Kirsner RS
J Am Acad Dermatol; 2009 Jun; 60(6):951-5. PubMed ID: 19344978
[TBL] [Abstract][Full Text] [Related]
12. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
[TBL] [Abstract][Full Text] [Related]
13. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds.
Loots MA; Lamme EN; Zeegelaar J; Mekkes JR; Bos JD; Middelkoop E
J Invest Dermatol; 1998 Nov; 111(5):850-7. PubMed ID: 9804349
[TBL] [Abstract][Full Text] [Related]
14. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers.
Cowin AJ; Hatzirodos N; Holding CA; Dunaiski V; Harries RH; Rayner TE; Fitridge R; Cooter RD; Schultz GS; Belford DA
J Invest Dermatol; 2001 Nov; 117(5):1282-9. PubMed ID: 11710945
[TBL] [Abstract][Full Text] [Related]
15. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers.
Drinkwater SL; Burnand KG; Ding R; Smith A
J Vasc Surg; 2003 Nov; 38(5):1106-12. PubMed ID: 14603223
[TBL] [Abstract][Full Text] [Related]
16. Time- and dose-dependent effects of chronic wound fluid on human adult dermal fibroblasts.
De Mattei M; Ongaro A; Magaldi S; Gemmati D; Legnaro A; Palazzo A; Masieri F; Pellati A; Catozzi L; Caruso A; Zamboni P
Dermatol Surg; 2008 Mar; 34(3):347-56. PubMed ID: 18177397
[TBL] [Abstract][Full Text] [Related]
17. Development of an enhanced proteomic method to detect prognostic and diagnostic markers of healing in chronic wound fluid.
Fernandez ML; Broadbent JA; Shooter GK; Malda J; Upton Z
Br J Dermatol; 2008 Feb; 158(2):281-90. PubMed ID: 18070206
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
19. Effect of venous ulcer exudates on angiogenesis in vitro.
Drinkwater SL; Smith A; Sawyer BM; Burnand KG
Br J Surg; 2002 Jun; 89(6):709-13. PubMed ID: 12027980
[TBL] [Abstract][Full Text] [Related]
20. Multiple fragments related to angiostatin and endostatin in fluid from venous leg ulcers.
Smith E; Hoffman R
Wound Repair Regen; 2005; 13(2):148-57. PubMed ID: 15828939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
